<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Di Vito, Luca</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Optical Coherence Tomography and Drug-Eluting Stents</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-09-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-12</style></pages><abstract><style  face="normal" font="default" size="100%">Optical coherence tomography (OCT) is a low-penetration imaging technique with 10 μm to 15 μm resolution that can be used to view atherosclerotic plaque. Unlike intravascular ultrasound (IVUS), OCT can identify inflammatory cells (macrophages) in plaque. This article discussed assessment of atherosclerotic plaque and drug-eluting stents with OCT.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>